DaVita schedules Q2 2026 investor conference call
The call will discuss results on August 4 at 5 p.m. ET, with webcast available.
See the latest news and media coverage for DaVita. We track all announcements, press releases, and industry mentions in real time, all in one place.
Provider of kidney care and dialysis services
davita.comLast updated
In short: DaVita reported strong 2026 earnings, expanded AI-integrated kidney care, and agreed to a $15 million settlement over a data breach.
The call will discuss results on August 4 at 5 p.m. ET, with webcast available.
The kidney care leader focuses on patient outcomes, teammate opportunities, and environmental resilience, building on prior five-year goals.
Revenues reached $3.416 billion, operating income $482 million, and diluted EPS $2.87. The company repurchased 3 million shares.
The initiative promotes integrated cardiovascular, kidney, and metabolic care using evidence-based tools across 150 sites to improve outcomes and reduce costs. DaVita invests in AI and multidisciplinary teams.
DaVita (DVA) is back in focus after two meaningful developments. The company expanded its value based care partnership with Humana for chronic kidney...
DaVita stock held at $180.72 as August 4 results showed $4.02 EPS, $3.55 billion revenue and FY 2026 EPS guidance of 14.1 to 15.2.
See the latest DaVita Inc stock price (DVA:XNYS), related news, valuation, dividends and more to help you make your investing decisions.
DaVita (NYSE: DVA) recently received a number of ratings updates from brokerages and research firms: 8/7/2026 – DaVita was upgraded by TD Cowen from “hold...
Track DaVita and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.